Australia · Delayed Price · Currency is AUD SciDev Statistics
Total Valuation
SciDev has a market cap or net worth of AUD 30.41 million. The enterprise value is 25.40 million.
| Market Cap | 30.41M |
| Enterprise Value | 25.40M |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SciDev has 190.09 million shares outstanding. The number of shares has increased by 1.19% in one year.
| Current Share Class | 190.09M |
| Shares Outstanding | 190.09M |
| Shares Change (YoY) | +1.19% |
| Shares Change (QoQ) | +2.26% |
| Owned by Insiders (%) | 10.81% |
| Owned by Institutions (%) | 24.79% |
| Float | 123.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 53.33 |
| PS Ratio | 0.35 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | 10.00 |
| P/OCF Ratio | 8.43 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.94, with an EV/FCF ratio of 8.36.
| EV / Earnings | n/a |
| EV / Sales | 0.30 |
| EV / EBITDA | 14.94 |
| EV / EBIT | n/a |
| EV / FCF | 8.36 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.70 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | 1.17 |
| Interest Coverage | -4.88 |
Financial Efficiency
Return on equity (ROE) is -12.40% and return on invested capital (ROIC) is -6.51%.
| Return on Equity (ROE) | -12.40% |
| Return on Assets (ROA) | -2.25% |
| Return on Invested Capital (ROIC) | -6.51% |
| Return on Capital Employed (ROCE) | -5.46% |
| Weighted Average Cost of Capital (WACC) | 8.34% |
| Revenue Per Employee | 3.89M |
| Profits Per Employee | -262,136 |
| Employee Count | 22 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 8.94 |
Taxes
| Income Tax | -52,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.68, so SciDev's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 52.51 |
| Average Volume (20 Days) | 121,999 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SciDev had revenue of AUD 85.69 million and -5.77 million in losses. Loss per share was -0.03.
| Revenue | 85.69M |
| Gross Profit | 26.06M |
| Operating Income | -2.47M |
| Pretax Income | -5.82M |
| Net Income | -5.77M |
| EBITDA | 482,000 |
| EBIT | -2.47M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 8.57 million in cash and 3.55 million in debt, with a net cash position of 5.01 million or 0.03 per share.
| Cash & Cash Equivalents | 8.57M |
| Total Debt | 3.55M |
| Net Cash | 5.01M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 42.95M |
| Book Value Per Share | 0.23 |
| Working Capital | 11.57M |
Cash Flow
In the last 12 months, operating cash flow was 3.61 million and capital expenditures -567,000, giving a free cash flow of 3.04 million.
| Operating Cash Flow | 3.61M |
| Capital Expenditures | -567,000 |
| Depreciation & Amortization | 2.95M |
| Net Borrowing | -2.95M |
| Free Cash Flow | 3.04M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 30.41%, with operating and profit margins of -2.88% and -6.73%.
| Gross Margin | 30.41% |
| Operating Margin | -2.88% |
| Pretax Margin | -6.79% |
| Profit Margin | -6.73% |
| EBITDA Margin | 0.56% |
| EBIT Margin | -2.88% |
| FCF Margin | 3.55% |
Dividends & Yields
SciDev does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.19% |
| Shareholder Yield | -1.19% |
| Earnings Yield | -18.96% |
| FCF Yield | 10.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 3, 2018. It was a reverse split with a ratio of 0.1.
| Last Split Date | Dec 3, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
SciDev has an Altman Z-Score of 1.57 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 4 |